Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$132.94
-2.2%
$163.15
$127.70
$262.87
$9.85B1.651.25 million shs1.52 million shs
DaVita Inc. stock logo
DVA
DaVita
$132.29
-3.2%
$138.83
$126.07
$179.60
$9.77B1.13671,653 shs605,122 shs
DexCom, Inc. stock logo
DXCM
DexCom
$76.00
-3.1%
$81.14
$57.52
$93.25
$30.74B1.483.75 million shs4.89 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$91.51
-1.6%
$93.74
$74.07
$116.65
$8.01B0.51.24 million shs790,954 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
-0.68%-0.90%-2.82%-26.71%-38.60%
DaVita Inc. stock logo
DVA
DaVita
+1.70%-0.07%+5.54%-0.96%-8.99%
DexCom, Inc. stock logo
DXCM
DexCom
+0.51%+5.52%-0.58%-5.53%+12.47%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-0.08%+4.66%-0.06%-11.07%+21.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$132.94
-2.2%
$163.15
$127.70
$262.87
$9.85B1.651.25 million shs1.52 million shs
DaVita Inc. stock logo
DVA
DaVita
$132.29
-3.2%
$138.83
$126.07
$179.60
$9.77B1.13671,653 shs605,122 shs
DexCom, Inc. stock logo
DXCM
DexCom
$76.00
-3.1%
$81.14
$57.52
$93.25
$30.74B1.483.75 million shs4.89 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$91.51
-1.6%
$93.74
$74.07
$116.65
$8.01B0.51.24 million shs790,954 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
-0.68%-0.90%-2.82%-26.71%-38.60%
DaVita Inc. stock logo
DVA
DaVita
+1.70%-0.07%+5.54%-0.96%-8.99%
DexCom, Inc. stock logo
DXCM
DexCom
+0.51%+5.52%-0.58%-5.53%+12.47%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-0.08%+4.66%-0.06%-11.07%+21.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.50
Moderate Buy$215.0061.73% Upside
DaVita Inc. stock logo
DVA
DaVita
1.75
Reduce$158.0019.43% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.91
Moderate Buy$99.8931.44% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
3.00
Buy$119.7730.88% Upside

Current Analyst Ratings Breakdown

Latest DVA, ALGN, DXCM, and HQY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/10/2025
DaVita Inc. stock logo
DVA
DaVita
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetUnderperform$145.00 ➝ $140.00
9/8/2025
DexCom, Inc. stock logo
DXCM
DexCom
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformMarket Perform
9/3/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$130.00 ➝ $134.00
9/3/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$125.00 ➝ $126.00
9/3/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$109.00 ➝ $110.00
9/1/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
8/29/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$125.00
8/28/2025
HealthEquity, Inc. stock logo
HQY
HealthEquity
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$117.00 ➝ $109.00
8/21/2025
DexCom, Inc. stock logo
DXCM
DexCom
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$100.00
8/8/2025
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$148.00
8/7/2025
DaVita Inc. stock logo
DVA
DaVita
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$169.00 ➝ $160.00
(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B2.41$8.79 per share15.12$51.60 per share2.58
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.74$18.53 per share7.14$4.83 per share27.39
DexCom, Inc. stock logo
DXCM
DexCom
$4.03B7.39$2.18 per share34.88$5.38 per share14.13
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.20B6.57$4.20 per share21.81$24.91 per share3.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.9322.4214.851.5311.04%13.36%8.32%10/22/2025 (Estimated)
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.1713.0110.410.986.35%369.39%4.62%11/4/2025 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.4452.7830.891.6413.29%30.41%10.08%10/23/2025 (Estimated)
HealthEquity, Inc. stock logo
HQY
HealthEquity
$96.70M$1.6555.4632.221.3311.49%12.04%7.44%N/A

Latest DVA, ALGN, DXCM, and HQY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
DaVita Inc. stock logo
DVA
DaVita
$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion
7/30/2025Q2 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.57$2.49-$0.08$1.72$1.06 billion$1.01 billion
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45$0.48+$0.03$0.45$1.13 billion$1.16 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.23
1.10
DaVita Inc. stock logo
DVA
DaVita
23.18
1.39
1.34
DexCom, Inc. stock logo
DXCM
DexCom
0.48
1.52
1.35
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.47
4.23
4.23

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
DaVita Inc. stock logo
DVA
DaVita
90.12%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
DaVita Inc. stock logo
DVA
DaVita
1.50%
DexCom, Inc. stock logo
DXCM
DexCom
0.32%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00071.50 million70.43 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.15 million390.90 millionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
3,12086.16 million84.86 millionOptionable

Recent News About These Companies

Royal Bank of Canada Lowers Holdings in HealthEquity, Inc. $HQY
Q3 EPS Estimates for HealthEquity Boosted by Analyst
Deutsche Bank Sticks to Their Buy Rating for Healthequity (HQY)
Analysts Set Expectations for HealthEquity Q4 Earnings
Q4 EPS Estimates for HealthEquity Decreased by Analyst
HealthEquity (NASDAQ:HQY) Shares Gap Up on Analyst Upgrade

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$132.94 -2.99 (-2.20%)
Closing price 04:00 PM Eastern
Extended Trading
$133.18 +0.24 (+0.18%)
As of 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

DaVita stock logo

DaVita NYSE:DVA

$132.29 -4.42 (-3.23%)
Closing price 03:59 PM Eastern
Extended Trading
$132.22 -0.07 (-0.06%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

DexCom stock logo

DexCom NASDAQ:DXCM

$76.00 -2.40 (-3.06%)
Closing price 04:00 PM Eastern
Extended Trading
$76.28 +0.28 (+0.36%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$91.51 -1.48 (-1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$92.00 +0.49 (+0.54%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.